TAMPA — With Biovest International's emergence from Chapter 11 bankruptcy, the biomedical firm has named a new CEO to transition the reorganized, recapitalized company from the clinical stage to the commercial stage.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition